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Introduction. Rosacea is a common, chronic disorder that can present with a variety of 
cutaneous or ocular manifestations. Skin involvement primarily affects the central face, with 
findings such as persistent centrofacial redness, papules, pustules, flushing, telangiectasia, and 
phymatous skin changes. Ocular involvement may also occur, manifesting with lid margin 
telangiectases, conjunctival injection, ocular irritation, or other signs and symptoms. The 
worldwide epidemiology of rosacea remains unknown, although it is a common condition 
associated with other diseases outside the skin.  
Aim of the study. To perform a review of the published literature to examine the global 
epidemiology of rosacea.  
Materials and methods. A systematic review of population‐based and dermatological 
outpatient studies reporting frequency of rosacea was performed using three electronic medical 
databases: PubMed (7), Embase (5) and Web of Science (4)  
Results. Rosacea affects mainly adults around the age of 30 years and classically predominates 
in females. Recent Estonian and Irish studies suggest that the female predominance may not be 
as high as previously believed. However, prevalence does increase with age. The prevalence 
statistics published in Europe and the United States are highly variable, ranging from less than 
1% to more than 20% of the adult population. Rosacea has been reported in countries whose 
populations have significant proportions of people with skin of color throughout Africa, Asia, 
and South America, with rates up to 10%.Although only 15 cases of rosacea were observed in 
a South African dermatology clinic over an 8-year period, during which 6700 patients were 
examined, all of these cases occurred in patients with Fitzpatrick skin phototype V( Dlova, 
N.C. and Mosam, Clin Exp Dermatol. 2017) Likewise, an epidemiologic study in Colombia 
reported a rosacea prevalence of <3%, but ∼12% of the 291 patients with rosacea had 
Fitzpatrick skin phototype IV or V (Rueda, L.J., Motta, A., Pabon, Int J Dermatol. 2017) . An 
even greater percentage was revealed in a study of 168 Korean patients with rosacea; nearly 
40% of these patients had Fitzpatrick skin phototype IV or V (Bae, Y.I., Yun, S.J., Lee, J.B., 
Kim, S.J., Won, Y.H., and Lee, S.C. Ann Dermatol. 2009). Rosacea diagnosis in patients with 
darker skin has also been reported in European countries. An analysis of 348 workers in Estonia 
showed a 20% prevalence of rosacea, with 55% of cases occurring in patients with Fitzpatrick 
skin phototypes I and II, as would be expected.Also, the Estonian study also showed that ∼38% 
of the patients had Fitzpatrick skin phototype III and 7% had phototype IV.   
Conclusions. Estimated worldwide epidemiology of rosacea based on published data and 
found that 5-46% of the adult population is affected. However, the prevalence of rosacea 
depended on the diagnostic method, with higher estimates in questionnaire studies of rosacea 
symptoms and lower estimates in health registries with International Classification of Diseases 
codes.  
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